Quality of Life of Women After a First Diagnosis of Breast Cancer Using a Self-Management Support mHealth App in Taiwan: Randomized Controlled Trial

• DOI: 10.2196/17084
• Publication Date: 2020-01-27T02:37:57Z
• Authors: I-Ching Hou; Hsin-Yi Lin; Shan-Hsiang Shen; King-Jen Chang; Hao-Chih Tai; Ay-Jen Tsai; Patricia C Dykes
• Keywords: mHealth; Self-Management

Background There are over 2 million newly diagnosed patients with breast cancer worldwide more than 10,000 cases in Taiwan each year. During 2017-2018, the National Yang-Ming University, University of Science and Technology, Breast Cancer Prevention Foundation collaborated to develop a self-management support (BCSMS) mHealth app for Taiwanese women cancer. Objective The aim this study was investigate quality life (QoL) after using BCSMS app. Methods After receiving first diagnosis cancer, stage 0 III who were recruited from social networking sites or referred by their oncologists oncology case managers, randomized 1:1 into intervention control groups. Intervention group subjects used received usual care. Two questionnaires—the European Organization Research Treatment (EORTC) Quality-of-Life Questionnaire Core 30 (QLQ-C30) EORTC Cancer-Specific (QLQ-BR23)—were distributed both arms. Paper-based questionnaires at baseline; paper-based Web-based 1.5-month 3-month follow-up evaluations. All evaluations self-assessed anonymous, participants blinded allocation Descriptive analysis, Pearson chi-square test, analysis variance, generalized estimating equation analyze data. Missing values, without multi-imputation techniques, sensitivity analysis. Results A total 112 enrolled randomly allocated either experimental (n=53) (n=59). completion rate 89.3% (100/112). demographic data showed homogeneity between two groups age (range 50-64 years), (stage II), marital status (married), working (employed), treatment (receiving treatments). mean QoL summary scores QLQ-C30 (83.45 vs 82.23, P=.03) QLQ-BR23 (65.53 63.13, P=.04) significantly higher among versus group, respectively, 3 months. Conclusions This research provides mobile health care promote could be disease self-management, further evaluation whether is sustained warranted. Trial Registration ClinicalTrials.gov NCT004174248; https://clinicaltrials.gov/ct2/show/NCT04174248